LS Investment Advisors’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-2,904
Closed -$277K 667
2021
Q1
$277K Sell
2,904
-1,892
-39% -$173K 0.02% 614
2020
Q4
$381K Hold
4,796
0.02% 523
2020
Q3
$297K Sell
4,796
-136
-3% -$8.85K 0.02% 558
2020
Q2
$326K Buy
4,932
+80
+2% +$4.79K 0.02% 517
2020
Q1
$230K Hold
4,852
0.02% 578
2019
Q4
$266K Buy
4,852
+1,472
+44% +$77.2K 0.01% 691
2019
Q3
$165K Buy
3,380
+312
+10% +$15.6K 0.01% 856
2019
Q2
$160K Sell
3,068
-468
-13% -$23.6K 0.01% 889
2019
Q1
$176K Sell
3,536
-328
-8% -$14.8K 0.01% 849
2018
Q4
$140K Sell
3,864
-2,084
-35% -$87K 0.01% 905
2018
Q3
$304K Sell
5,948
-656
-10% -$29.1K 0.02% 683
2018
Q2
$244K Sell
6,604
-16
-0.2% -$611 0.01% 783
2018
Q1
$250K Sell
6,620
-768
-10% -$27.1K 0.01% 759
2017
Q4
$239K Sell
7,388
-1,940
-21% -$61.6K 0.01% 804
2017
Q3
$282K Buy
9,328
+972
+12% +$28.8K 0.02% 787
2017
Q2
$245K Buy
8,356
+1,508
+22% +$41.2K 0.02% 816
2017
Q1
$174K Buy
6,848
+2,280
+50% +$58.9K 0.01% 905
2016
Q4
$117K Buy
4,568
+400
+10% +$10.5K 0.01% 992
2016
Q3
$114K Buy
4,168
+532
+15% +$14.6K 0.01% 966
2016
Q2
$103K Buy
+3,636
New +$93.5K 0.01% 989

Other funds holding TECH

LS Investment Advisors's TECH Position: Q2 2021 in Review

LS Investment Advisors sold out of Bio-Techne (TECH) in Q2 2021, closing a stake of 2,904 shares — an estimated $277K sold.

LS Investment Advisors first reported a position in TECH in Q2 2016 and held it in 20 quarters. The position peaked at $381K in Q4 2020. 513 funds tracked by Wall St. Rank hold TECH as of Q2 2021.

  • LS Investment Advisors reported no remaining Bio-Techne position as of Q2 2021 after selling out during the quarter.
  • LS Investment Advisors sold 2,904 Bio-Techne shares in Q2 2021, an estimated $277K.
  • LS Investment Advisors first reported a position in Bio-Techne in Q2 2016 and held it in 20 quarters.
  • LS Investment Advisors's Bio-Techne position peaked at $381K in Q4 2020.
  • 513 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2021.

Based on LS Investment Advisors's 13F filing for Q2 2021, filed 11 Aug 2021.